Matthew Philip Goetz, MD

  • 8931 Citations
  • 43 Scopus h-Index
20022020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Comment/debate
2018

The development of endoxifen for breast cancer

Goetz, M. P., Feb 1 2018, In : Clinical Advances in Hematology and Oncology. 16, 2, p. 102-105 4 p.

Research output: Contribution to journalComment/debate

2013

Tamoxifen use in postmenopausal breast cancer: CYP2D6 matters

Brauch, H., Schroth, W., Goetz, M. P., Mürdter, T. E., Winter, S., Ingle, J. N., Schwab, M. & Eichelbaum, M., Jan 10 2013, In : Journal of Clinical Oncology. 31, 2, p. 176-180 5 p.

Research output: Contribution to journalComment/debate

85 Scopus citations
2010

Clinical implementation of pharmacogenomics: Overcoming genetic exceptionalism

Relling, M. V., Altman, R. B., Goetz, M. P. & Evans, W. E., Jun 2010, In : The Lancet Oncology. 11, 6, p. 507-509 3 p.

Research output: Contribution to journalComment/debate

70 Scopus citations
2009

Tamoxifen, endoxifen, and CYP2D6: The rules for evaluating a predictive factor

Goetz, M. P., Dec 17 2009, In : ONCOLOGY. 23, 14

Research output: Contribution to journalComment/debate

7 Scopus citations
2005

Targeted therapy for BRCA2 deficient tumors

Goetz, M. & Couch, F. J., Jul 2005, In : Cancer Biology and Therapy. 4, 7, p. 707-708 2 p.

Research output: Contribution to journalComment/debate

Open Access
1 Scopus citations